1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Dysembryoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berthou, C; Bourge, JF; Denizot, Y; Fleet, C; Geromin, D; Leboulch, P; Michel, E; Pawliuk, R; Sasportes, M; Sigaux, F; Soulié, A | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Dysembryoma
| Article | Year |
|---|---|
Glycoprotein 170 induces platelet-activating factor receptor membrane expression and confers tumor cell hypersensitivity to NK-dependent cell lysis.
Topics: ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Embryonal; Cell Line, Tumor; Cell Membrane; Clone Cells; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; Genes, MDR; Glycoproteins; Humans; Hydrogen-Ion Concentration; K562 Cells; Killer Cells, Natural; Leukemia, Erythroblastic, Acute; Paclitaxel; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Retroviridae; Teratoma; Transduction, Genetic; Transfection | 2004 |